JP Morgan Chase
IMGN

JP Morgan Chase’s Immunogen Inc IMGN Stock Holding History

JP Morgan Chase’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,063,254
Closed -$61.2M – 8076
2023
Q4 		$61.2M Sell
2,063,254
-135,173
-6% -$2.69M 0.01% 1116
2023
Q3 		$34.9M Buy
2,198,427
+1,336,005
+155% +$22.2M ﹤0.01% 1296
2023
Q2 		$16.3M Sell
862,422
-106,311
-11% -$1.26M ﹤0.01% 1857
2023
Q1 		$3.72M Buy
968,733
+752,266
+348% +$3.21M ﹤0.01% 3047
2022
Q4 		$1.07M Buy
216,467
+82,963
+62% +$450K ﹤0.01% 3991
2022
Q3 		$638K Buy
133,504
+7,452
+6% +$39.3K ﹤0.01% 4299
2022
Q2 		$568K Buy
126,052
+479
+0.4% +$2.08K ﹤0.01% 4475
2022
Q1 		$598K Buy
125,573
+30,112
+32% +$167K ﹤0.01% 4592
2021
Q4 		$709K Buy
95,461
+7,191
+8% +$44.7K ﹤0.01% 4617
2021
Q3 		$500K Buy
88,270
+1,258
+1% +$7.27K ﹤0.01% 4720
2021
Q2 		$573K Buy
87,012
+14,534
+20% +$101K ﹤0.01% 4611
2021
Q1 		$587K Sell
72,478
-14,609
-17% -$119K ﹤0.01% 4580
2020
Q4 		$562K Buy
87,087
+17,797
+26% +$104K ﹤0.01% 4303
2020
Q3 		$246K Buy
69,290
+8,241
+13% +$33.3K ﹤0.01% 4273
2020
Q2 		$280K Buy
61,049
+3,214
+6% +$13.7K ﹤0.01% 4111
2020
Q1 		$197K Sell
57,835
-317,619
-85% -$1.39M ﹤0.01% 4274
2019
Q4 		$1.92M Buy
375,454
+296,201
+374% +$1.01M ﹤0.01% 3418
2019
Q3 		$191K Sell
79,253
-1,322,384
-94% -$3.51M ﹤0.01% 4654
2019
Q2 		$2.87M Buy
1,401,637
+1,363,842
+3,609% +$3.23M ﹤0.01% 3124
2019
Q1 		$102K Sell
37,795
-1,506
-4% -$6.52K ﹤0.01% 4882
2018
Q4 		$189K Buy
39,301
+3,644
+10% +$22.1K ﹤0.01% 4618
2018
Q3 		$338K Buy
35,657
+7,837
+28% +$75.3K ﹤0.01% 4470
2018
Q2 		$270K Buy
27,820
+6,278
+29% +$66.2K ﹤0.01% 4439
2018
Q1 		$227K Sell
21,542
-411,120
-95% -$4.06M ﹤0.01% 4328
2017
Q4 		$2.77M Buy
432,662
+431,871
+54,598% +$2.66M ﹤0.01% 3116
2017
Q3 		$6K Buy
791
+108
+16% +$718 ﹤0.01% 4784
2017
Q2 		$5K Sell
683
-186,547
-100% -$854K ﹤0.01% 4769
2017
Q1 		$725K Buy
187,230
+186,730
+37,346% +$545K ﹤0.01% 3550
2016
Q4 		$1K Buy
+500
New +$1K ﹤0.01% 4970
2016
Q3 		– Sell
-97
Closed – – 4878
2016
Q2 		$0 Sell
97
-1,185
-92% -$7.43K ﹤0.01% 5012
2016
Q1 		$11K Buy
1,282
+1,119
+687% +$9.47K ﹤0.01% 4233
2015
Q4 		$2K Buy
+163
New +$2.01K ﹤0.01% 4538
2013
Q4 		– Sell
-76,467
Closed -$1.3M – 4279
2013
Q3 		$1.3M Sell
76,467
-29,201
-28% -$513K ﹤0.01% 3102
2013
Q2 		$1.75M Buy
+105,668
New +$1.71M ﹤0.01% 2889

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

JP Morgan Chase's IMGN Position: Q1 2024 in Review

JP Morgan Chase sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 2,063,254 shares — an estimated $61.2M sold.

JP Morgan Chase first reported a position in IMGN in Q2 2013 and held it in 34 quarters. The position peaked at $61.2M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • JP Morgan Chase reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • JP Morgan Chase sold 2,063,254 Immunogen Inc shares in Q1 2024, an estimated $61.2M.
  • JP Morgan Chase first reported a position in Immunogen Inc in Q2 2013 and held it in 34 quarters.
  • JP Morgan Chase's Immunogen Inc position peaked at $61.2M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.